ALPHARETTA, Ga., March 15,
2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:
AVNS) today announced that Michael Greiner, senior vice
president, chief financial officer and chief transformation
officer, will present and participate in an analyst-led fireside
chat at the 2023 virtual KeyBanc Capital Markets Life Sciences
& MedTech Investor Forum on Wed., March 22 at
approximately 9:45 a.m., ET.
A webcast of the conference presentation will be available on
the Investors section of the Avanos Medical website and
will be archived on that site.
About Avanos Medical: Avanos Medical, Inc. (NYSE:
AVNS) is a medical technology company focused on delivering
clinically superior medical device solutions that will help
patients get back to the things that matter. Headquartered in
Alpharetta, Georgia, we are
committed to addressing some of today's most important healthcare
needs, including providing a vital lifeline for nutrition to
patients from hospital to home, and reducing the use of opioids
while helping patients move from surgery to recovery. We develop,
manufacture and market our recognized brands globally and hold
leading market positions in multiple categories across our
portfolio. For more information, visit Avanos.com and follow Avanos
Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-2023-virtual-keybanc-capital-markets-life-sciences--medtech-investor-forum-301772828.html
SOURCE Avanos Medical, Inc.